VC enters Longevity market with K4Connect deal

We talk with VC investor Forte Ventures about its first foray into AgeTech, COVID-19 and the Longevity investment opportunity.

Longevity agetech company K4Connect has announced a $7.7 million finance injection, bringing its Series B VC funding round to a total of $21 million. The North Carolina based firm is a provider of smart technologies for senior living communities and serves thousands of residents at over 800 care homes, independent living and assisted living communities across the USA.

The company will apply the new funds to further accelerate the development and deployment of solutions that address the challenges brought on by COVID-19, which has had far-reaching implications for senior living. Billed as a single “operating system” for senior living communities, the K4Community solution brings together a range of smart products for residents, staff and operators in a single, simple interface.

K4Connect Scott Moody CEO

The new funding round was led by institutional VC firm Forte Ventures. We caught up with Forte partner Louis Rajczi to find out what led his firm to get involved in its first investment in the Longevity sector.

“For K4Connect specifically, it starts with an extremely capable and experienced management team, who have “done this before” with other startup companies, and who have a commitment and belief in their mission to be able to dramatically improve people’s lives,” says Rajczi. “In addition to the team, we believe K4Connect has identified a way to successfully package and sell technology offerings into the senior living market. While the company is still at the early stages, there are clear indications that it is on the right track and fully committed to developing the customer relationships required to broaden the availability of the K4Connect solutions.”

Rajczi also points out the importance of the strong relationships Forte has with a number of K4Connect’s co-investors.

“And we know the strategic partners they have around the table, including AXA Venture Partners, Ziegler Link-Age, and Intel Capital, will bring tremendous value to help the company grow,” he adds. “We believe the combination of all these elements will position the company well for success.”

Rajczi expects the next few years to be both exciting and challenging for K4Connect – even without the extra challenges presented by the coronavirus pandemic.

“The company is at a stage now where its technology is being deployed at scale and we will soon be able to get detailed feedback from customers, not only on how well the current solutions address their issues, but also on other things they would like to see the technology do for them in the future,” he says. “It is also a time when more and more intelligent, connected consumer devices are coming on to the market that could be incorporated as part of these new solutions.”

In the context of COVID-19, Rajczi believes companies looking at buying AgeTech and care-related technologies are being impacted in the same ways as most other companies.

“Crises like these tend to expose weaknesses and faults in the “normal” way of doing business, and force companies to adapt because the old way of doing business is no longer feasible,” he says. “In some cases, it changes a “nice to have” technology to a “must have” technology, or one that would be considered as part of “next year’s budget” into one that is needed immediately. Any time there is change, new opportunities arise, and I believe investors will identify where these new opportunities are being created – including in the AgeTech sector.”

All companies are having to adapt to accommodate to the changes in the world around them, and Rajczi points out that some will do this more successfully than others.

“As a specific example, K4Connect has developed a zero-touch, plug and play deployment model to allow facilities to receive pre-configured equipment that works straight out of the box,” he says. “This will help customers roll out the K4Connect solution despite the current restrictions limiting outside visitors from entering senior living facilities.”

K4 Connect and Amazon have announced an initiative to provide more support to senior living residents during the outbreak distributing 8,000 Echo Dots

Despite this being Forte’s first AgeTech investment, Rajczi indicates that the company “remains open to making further investments in the AgeTech sector, but are approaching it from an opportunistic perspective rather than with a specific thesis in mind.”

Regarding the investment opportunity for the wider Longevity sector, Rajczi is optimistic.

“At Forte Ventures, we believe we’re at the very early stages of discovery for a host of ways to improve human health and lifespan; and not by small increments, but by significant amounts,” he says. “Whether related to technology (e.g. benefits derived from the utilization of genome editing tools like CRISPR/Cas9), diet, emergency and/or surgical care, there are many reasons to agree with those on the front lines who believe that aging and age related decline are the result of correctable errors in the system, and not the natural, unalterable, and inevitable course of events.”

As an investor, Rajczi feels this presents opportunities, not only in the technologies specifically related to increasing human lifespan, but also in tangential areas.

“For example, how will companies benefit/change when employees could remain active and engaged longer, pushing off retirement until age 100?” he asks. “How might the real estate market change when people are capable of staying in their homes and remaining independent until the age of 120? It is an exciting time to be alive, and by all current indications, the excitement is likely to last longer for me than it did for my grandparents.”

Danny Sullivan
Contributing Editor Danny has worked in technology communications for more than 15 years, spanning Europe and North America. From bionics and lasers to software and pharmaceuticals – and everything in between – he’s covered it all. Danny has wide experience of technology publishing and technical writing and has specific interest in the transfer from idea to market.

Latest articles

Evidence for tenth hallmark of aging increases with new paper

Is ten the new nine? Additional research adds weight to the argument that extracellular matrix stiffening should be considered the tenth hallmark of aging. Since...

Help us help you: Longevity biotech survey

A new survey on translational processes and hurdles to clinical trials in Longevity biotech. We're working with two MDs: Oliver Zolman and Jian Fransen, on...

First Longevity announces first investors for current round

Some news of our own: European VC fund and a Longevity innovator participate in the First Longevity funding round. Last week we announced that Tom...

GDF15 protects from age‐related metabolic phenotypes

A recent study shows an important role for GDF15 in preventing aging-induced metabolic phenotypes by modulating systemic inflammatory responses in humans and mice. Dysfunction of...